Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Studies with the high-affinity antiestrogen, (/sup 3/H)HI285

Thesis/Dissertation ·
OSTI ID:7170916

Antiestrogens are compounds that inhibit some of the actions of estrogens. Certain antiestrogens, notably the triphenylethylene, tamoxifen, are useful in the treatment of female breast cancer. The triphenylethylene antiestrogen, HI285, was labelled with radioactive hydrogen ((/sup 3/H)) for use as a probe of antiestrogen action. Radioactive HI285 ((/sup 3/H)HI285) bound to the cytosolic estrogen receptor from both rat and calf uterus and competed with estradiol for the estrogen specific binding site. In both animals (/sup 3/H)HI285 displayed a higher affinity for the estrogen receptor and a slower dissociation rate from the receptor than did estradiol. (/sup 3/H)HI285, as well as estradiol, appeared to trigger receptor activation. Studies using the activation blocker, sodium molybdate, indicated that (/sup 3/H)HI285 triggered activation in a manner different from estradiol. The non-activated estrogen receptor from calf uterus, when occupied by (/sup 3/H)estradiol, existed as two discrete forms that could be separated by ion-exchange chromatography. In contrast, the (/sup 3/H)HI285-occupied receptor existed as a single form.

Research Organization:
Saint Louis Univ., MO (USA)
OSTI ID:
7170916
Country of Publication:
United States
Language:
English